AZBio President & CEO, Joan Koerber-Walker, shares highlights of health innovations being discovered, developed and delivered in Arizona with Members of the House Health Committee in the Arizona House of Representatives on March 9, 2017.
Click here to watch the short video
The diagnosis, understanding and management of Crohn’s disease may have just received a helping hand from a joint Biodesign Institute and Mayo Clinic study aimed at developing a better blood test for the disease. Continue reading
Crowd funding campaign launches to start clinical study for TGen-developed diagnostic test. Continue reading
HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced that Ann F. Hanham, Ph.D., a director since August 2016, has been appointed to the Chair of the company’s board of directors. Continue reading
AZBio Board Member, Joshua L. LaBaer, MD, PhD, is being honored at Founders’ Day with the Faculty Research Achievement Award for his groundbreaking work in the emerging field of personalized medicine. Continue reading
NuvOx Pharma announces that the first patients have been dosed in a Phase Ib/II clinical trial for NVX-208, an oxygen therapeutic being developed for acute ischemic stroke. Continue reading
Do YOU have news to share with our community?
Send your news and events to JKW@AZBio.org.